BIOMAT Database Logo BIOMAT Database Logo

Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutators. 2015

Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Laboratory for Antimicrobial Pharmacodynamics, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, SUNY, Buffalo, New York, USA.

The interplay between polymyxin B pharmacodynamics and pathogenicity was examined in Pseudomonas aeruginosa PAO1 and isogenic DNA repair-deficient mutators (mutM and mutS strains). Against mutS mutators, polymyxin B initial killing was concentration dependent, with >99.9% bacterial reduction at 2 h followed by regrowth and resistance. The pre- versus postexposed strains were inoculated real time into Galleria mellonella waxworms, resulting in increased median survival times from 20 h to 23 h (P < 0.001). Emergence of resistance in mutS P. aeruginosa resulted in attenuation of virulence.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009036 Moths Insects of the suborder Heterocera of the order LEPIDOPTERA. Antheraea,Giant Silkmoths,Giant Silkworms,Silkmoths, Giant,Silkworms, Giant,Antheraeas,Giant Silkmoth,Giant Silkworm,Moth,Silkmoth, Giant,Silkworm, Giant
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011112 Polymyxin B A mixture of polymyxins B1 and B2, obtained from BACILLUS POLYMYXA strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for treatment of infections with gram-negative bacteria, but may be neurotoxic and nephrotoxic. Aerosporin,Polymyxin B Sulfate
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Nitrate Respiration Promotes Polymyxin B Resistance in Pseudomonas aeruginosa.
February 2021, Antioxidants & redox signaling,
Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.
June 2005, The Journal of antimicrobial chemotherapy,
Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
[Polymyxin B in meningitis Pseudomonas aeruginosa].
November 1960, La Semana medica,
Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.
September 2005, Antimicrobial agents and chemotherapy,
Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance.
October 1989, Antimicrobial agents and chemotherapy,
Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa.
October 1984, Antimicrobial agents and chemotherapy,
Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Treatment of pseudomonas aeruginosa ulcer with polymyxin B.
October 1952, A.M.A. archives of ophthalmology,
Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Rapid Polymyxin/Pseudomonas NP test for rapid detection of polymyxin susceptibility/resistance in Pseudomonas aeruginosa.
September 2020, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Infections with Pseudomonas aeruginosa treated with polymyxin B.
January 1952, A.M.A. archives of internal medicine,
Zackery P Bulman, and Mark D Sutton, and Neang S Ly, and Jurgen B Bulitta, and Patricia N Holden, and Roger L Nation, and Jian Li, and Brian T Tsuji
Characterization of the polymyxin B resistome of Pseudomonas aeruginosa.
January 2013, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!